Clinical Laserthermia Systems Feed

2026-11-12 15:05:00 LITT Behandling av Glioblastom med CLS Icke-kylda Lasersystem visar Lovande Resultat

2026-11-12 15:05:00 LITT Treatment of Glioblastoma with CLS Non-Cooled Laser System shows Promising Results

2026-10-29 08:30:00 CLS utsett som industripartner i ett femårigt forskningsprogram finansierat av NIH i USA för att vidareutveckla MR-ledd laserterapi för spinala metastaser 1,77 SEK | -0,56% | 0,18 MSEK

2026-10-29 08:30:00 CLS awarded as Industry Partner in NIH-Funded Five-Year Research Program in U.S to Advance MR-Guided Laser Therapy for Spinal Metastases 1,77 SEK | -0,56% | 0,18 MSEK

2026-09-07 14:30:00 CLS: Clinical Laserthermia Systems AB meddelar slutförandet av riktad emission 1,99 SEK | +4,95% | 0,17 MSEK

2026-09-07 14:30:00 CLS: Clinical Laserthermia Systems AB announces completion of directed issue 1,99 SEK | +4,95% | 0,17 MSEK

2026-09-03 20:30:00 CLS: Clinical Laserthermia Systems AB beslutar om riktad emission 1,90 SEK | +0,74% | 0,03 MSEK

2026-09-03 20:30:00 CLS: Clinical Laserthermia Systems AB resolves on a directed issue 1,90 SEK | +0,74% | 0,03 MSEK

2026-08-31 16:45:00 CLS: Clinical Laserthermia Systems AB announces completion of rights issue of units 1,86 SEK | -0,64% | 0,04 MSEK

2026-08-31 16:45:00 CLS: Clinical Laserthermia Systems AB meddelar slutförandet av företrädesemissionen av units 1,86 SEK | -0,64% | 0,04 MSEK

2026-08-31 08:30:00 CLS: Clinical Laserthermia Systems utser Katarina Lundqvist till permanent CFO 1,86 SEK | -0,64% | 0,04 MSEK

2026-08-31 08:30:00 CLS: Clinical Laserthermia Systems appoints Katarina Lundqvist as permanent CFO 1,86 SEK | -0,64% | 0,04 MSEK

2026-08-20 21:25:00 CLS: Clinical Laserthermia Systems AB tillkännager utfall i företrädesemission av units 1,89 SEK | +2,05% | 0,12 MSEK

2026-08-20 21:25:00 CLS: Clinical Laserthermia Systems AB announces outcome in rights issue of units 1,89 SEK | +2,05% | 0,12 MSEK

2026-08-18 08:30:00 CLS: Clinical Laserthermia Systems AB Ingår Avtal om Toppgaranti i Pågånde Företrädesemission av Units 1,81 SEK | -0,11% | 0,13 MSEK

2026-08-18 08:30:00 CLS: Clinical Laserthermia Systems AB Enters into Top-down Guarantee Agreement in Ongoing Rights Issue of Units 1,81 SEK | -0,11% | 0,13 MSEK

2026-08-13 08:30:00 CLS: Sista Dag för Teckning i Clinical Laserthermia Systems AB:s Företrädesemission av Units är den 18 augusti 2026 1,88 SEK | -0,63% | 0,05 MSEK

2026-08-13 08:30:00 CLS: Last Day of Subscription in Clinical Laserthermia Systems AB' Rights Issue of Units is 18 August 2026 1,88 SEK | -0,63% | 0,05 MSEK

2026-08-06 08:30:00 Majority of CLS Board and Key Executive Management Commit to Invest in the Company's Rights Issue 1,80 SEK | -2,17% | 0,17 MSEK

2026-08-06 08:30:00 Majoriteten av CLS styrelse och ledning förbinder sig att investera i bolagets nyemission 1,80 SEK | -2,17% | 0,17 MSEK

2026-08-04 08:30:00 CLS: Teckningsperioden för Clinical Laserthermia Systems AB:s företrädesemission av units börjar idag 1,85 SEK | -1,07% | 0,20 MSEK

2026-08-04 08:30:00 CLS: The Subscription Period in Clinical Laserthermia Systems AB' Rights Issue of Units Begins Today 1,85 SEK | -1,07% | 0,20 MSEK

2026-07-23 08:30:00 CLS: Board of Directors of Clinical Laserthermia Systems AB resolves on a rights issue of units of initially approximately SEK 39.5 million 1,96 SEK | -36,03% | 1,67 MSEK

2026-07-23 08:30:00 CLS: Styrelsen i Clinical Laserthermia Systems AB beslutar om en företrädesemission av units om initialt cirka 39,5 MSEK 1,96 SEK | -36,03% | 1,67 MSEK

2026-07-17 23:45:00 CLS Publishes Half-year Report January - June 2026

2026-07-17 23:45:00 CLS Publicerar Halvårsrapport januari - juni 2026

2026-06-29 19:20:00 CLS: Kommuniké från årsstämma måndagen den 29 juni i Clinical Laserthermia Systems AB 3,40 SEK | -4,31% | 0,06 MSEK

2026-06-29 19:20:00 CLS: Communique from the Annual General Meeting on Monday June 29th in Clinical Laserthermia Systems AB 3,40 SEK | -4,31% | 0,06 MSEK

2026-06-04 08:30:00 CLS: Clinical Laserthermia Systems publishes annual report for 2025 3,58 SEK | +0,98% | 0,12 MSEK

2026-06-04 08:30:00 CLS: Clinical Laserthermia Systems publicerar årsredovisning för 2025 3,58 SEK | +0,98% | 0,12 MSEK

2026-05-28 15:00:00 CLS enters research agreement with the U.S. National Cancer Institute 3,71 SEK | -9,20% | 1,31 MSEK

2026-05-28 08:30:00 CLS: Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 29, 2026 3,71 SEK | -9,20% | 1,31 MSEK

2026-05-28 08:30:00 CLS: Kallelse till årsstämma i Clinical Laserthermia Systems AB den 29 juni 2026 3,71 SEK | -9,20% | 1,31 MSEK

2026-05-12 08:30:00 CLS publicerar delårsrapport januari - mars 2026 4,65 SEK | -2,80% | 1,05 MSEK

2026-05-12 08:30:00 CLS Publishes Interim Report January - March 2026 4,65 SEK | -2,80% | 1,05 MSEK

2026-05-11 08:30:00 CLS Receives Largest Purchase Order Worth SEK 23 Million for Prism[®] Business 4,78 SEK | +37,41% | 4,24 MSEK

2026-04-28 10:45:00 CLS Strengthens its Strategic Partnership in Neurosurgery and Aims to Become Market Leader in Neuro LITT 4,25 SEK | -11,44% | 1,65 MSEK

2026-02-20 08:45:00 CLS publicerar Bokslutskommuniké januari - december 2025 5,14 SEK | -39,23% | 7,95 MSEK

2026-02-20 08:45:00 CLS: Clinical Laserthermia Systems AB publishes Year-end report January - December 2025 5,14 SEK | -39,23% | 7,95 MSEK

2026-01-08 08:30:00 CLS: TRANBERG[®] Thermal Therapy System installed at Andros Clinics for Launch of Ultrasound-Guided Focal Laser Ablation Program in The Netherlands 8,17 SEK | +12,55% | 2,19 MSEK

2025-12-12 21:00:00 CLS initiates recruitment process for permanent Chief Financial Officer

2025-12-03 08:30:00 CLS: Clinical Laserthermia Systems Submits CE-Marking Application for its ClearPoint Prism[®][ ]branded Neuro Laser Therapy System seeking European Regulatory Approval for use in Neurosurgery 7,06 SEK | +5,63% | 1,02 MSEK

2025-11-14 08:30:00 CLS Publishes Interim Report January - September 2025 8,26 SEK | -10,98% | 9,56 MSEK

2025-11-14 08:30:00 CLS publicerar delårsrapport januari - september 2025 8,26 SEK | -10,98% | 9,56 MSEK

2025-10-07 22:15:00 CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results 10,37 SEK | +31,00% | 3,97 MSEK

2025-09-30 13:35:00 CLS: Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B 8,76 SEK | -1,45% | 1,34 MSEK

2025-09-30 13:35:00 CLS: Clinical Laserthermia Systems AB tillförs 20,9 MSEK genom fullteckning av teckningsoptioner av serie TO 8 B 8,76 SEK | -1,45% | 1,34 MSEK

2025-09-04 17:00:47 CLS: Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[®] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT 11,70 SEK | +37,44% | 5,89 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode